Advertisement

Topics

Apellis Pharmaceuticals raises $60m in new funding round

06:13 EDT 11 Aug 2017 | Pharmaceutical Business Review

Apellis Pharmaceuticals has completed a $60m Series E preferred stock financing led by Sectoral Asset Management.

Original Article: Apellis Pharmaceuticals raises $60m in new funding round

NEXT ARTICLE

More From BioPortfolio on "Apellis Pharmaceuticals raises $60m in new funding round"

Quick Search
Advertisement